Hypogonadal men are more likely than those with normal testosterone to have prostate biopsy results showing high-grade PCa.
Quality studies are still needed to answer crucial questions about TRT and prostate cancer, cardiovascular risk.
Almost 1 in 3 not told cancer treatment might affect future fertility.
Study in England shows that that 1 in 12 black men die from the malignancy compared with 1 in 24 white men.
Results of a prospective study have implications for patient counseling.
No improvement in quality of life, even for patients with good baseline performance status.
The biomarkers PHI and PCA3 demonstrated high diagnostic accuracy in discriminating prostate cancer from prostatitis in re-biopsy candidates.
Statin use following diagnosis of localized PCa does not significantly reduce the risk of metastasis or death from PCa.
The finding is based on a study of men who underwent radical surgery for pT3aN0/NxR1 tumors but received no adjuvant or neoadjuvant therapy.
But research reveals association with pancreatic and prostate cancer.
Increased VTE risk among older patients, those with metastases, and those who underwent surgery.
But higher doses of radiation may improve survival in men with intermediate- and high-risk prostate cancers.
Upgrading, up staging linked to age 60, PSA 5.0 ng/ml, and 25 percent positive cores.
A range of foods, nutrients, and dietary patterns are being studied for prostate cancer prevention or treatment.
Pre-biopsy rectal swabs can be used to guide selection of a single antibiotic.
Many men with low-risk disease being spared prostatectomy, radiation, and androgen deprivation treatment.
Mortality rates predicted to meet Healthy People 2020 targets for breast, lung, and prostate cancers.
Researchers find 12% or fewer U.S. men with low-risk prostate cancer opt for active surveillance.
Overall, men with LUTS showed remarkably poor knowledge about their symptoms.
Researchers observe no association between prostate cancer and urethritis, orchitis, or epididymitis.
Radiation treatment is associated with an increased risk of requiring minimally invasive urologic procedures.
In a phase 2 trial, enzalutamide treatment was associated with significantly longer progression-free survival.
Age-adjusted prostate cancer-specific comorbidity index strongly predictive of other-cause mortality.
Each 20-unit increment in GPS was associated with a more than 2-fold increased likelihood of recurrence.
They are more likely to die and suffer complications compared with those admitted on weekdays.
The treatment was most effective in relief of macroscopic hematuria.
Researchers observed greater incidences of colorectal cancer among patients who underwent bilateral orchiectomy, surgery, and ADT.
A PHI of 82 discriminated between patients with and without biochemical recurrence.
Factors include younger age, aggressive disease, and concern that their malignancy is uncontrollable.
Smoking cessation for 10 or more years, however, mitigates that risk.
- High-Grade Prostate Cancer Linked to Low Testosterone
- Statin Use Fails To Prevent Progression to Lethal Prostate Cancer
- Erectile Function Worsens In Most Men After Prostate Biopsy
- Biomarkers Help Distinguish Prostate Cancer from Prostatitis
- Low Magnesium Linked to Worse Survival in Hemodialysis Patients
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)